Robert Falotico
Cordis US Corp. (United States) · 75 works · 8,279 citations · h-index 22
Top works
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
- Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries
- Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
- Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents
- Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries
- The Antiaggregating and Antithrombotic Activity of Clopidogrel Is Potentiated by Aspirin in Several Experimental Models in the Rabbit
- Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis
- Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent
- Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting Stents
- Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents
- 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents
- Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries
- Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives
- Positive Inotropic and Hemodynamic Properties of Flosequinan, a New Vasodilator, and a Sulfone Metabolite
- Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers
- Sirolimus-eluting stents: a review of experimental and clinical findings
- Heteroatom analogs of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones
- Novel Thiazole-Based Heterocycles as Selective Inhibitors of Fibrinogen-Mediated Platelet Aggregation
- Renal vasodilators. The role of the 4-substituent in isoquinolin-3-ol cardiovascular agents. 4-Ureido derivatives of isoquinolin-3-ol with selective renal vasodilator properties
- Low‐dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor